
    
      This study will be conducted with all participants receiving a dose of caffeine 100 mg on Day
      1 followed by a 7 day washout period before commencing 5 consecutive days of PBT2 250 mg from
      Day 8 to 12 and a second dose of caffeine 100 mg on Day 12. Pharmacokinetic samples will be
      collected during after each dose of the study drugs, along with safety monitoring
      assessments.
    
  